EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway

EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway

Lin Wang,1,2 Xianzi Wen,1 Fengming Luan,1 Tao Fu,2 Chao Gao,2 Hong Du,1 Ting Guo,1 Jing Han,1 Longtao Huangfu,1 Xiaojing Cheng,1 Jiafu Ji1,21Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Division of Gastrointestinal Cancer Translational Research Laboratory, Pek...

Full description

Bibliographic Details
Main Authors: Wang L, Wen X, Luan F, Fu T, Gao C, Du H, Guo T, Han J, Huangfu L, Cheng X, Ji J
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Cancer Management and Research
Subjects:
EIF3B
gastric cancer
prognosis
PI3K/AKT/mTOR pathway
Online Access:https://www.dovepress.com/eif3b-is-associated-with-poor-outcomes-in-gastric-cancer-patients-and--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/eif3b-is-associated-with-poor-outcomes-in-gastric-cancer-patients-and--peer-reviewed-article-CMAR

Similar Items